Developmental Research Program

发展研究计划

• 批准号: 10716160
• 负责人: GERTRAUD MASKARINEC
• 金额: $ 12.05万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-19 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10716160
• 关键词: Address; Area; Award; Behavioral; Biological; Cancer Burden; Cancer Center; Catchment Area; Characteristics; Clinical Trials; Collaborations; Community Outreach; Creativeness; Data; Development; Education; Educational workshop; Elements; Ensure; Equity; Ethnic Origin; Ethnic Population; Evaluation; Faculty; Fostering; Funding; Future; Goals; Hawaii; Human; Institution; Intervention; Investigation; Leadership; Malignant Neoplasms; Mentors; Minority Health Research; Mission; Monitor; National Cancer Institute; Outcome; Patient Care; Pilot Projects; Population Heterogeneity; Process; Request for Applications; Research; Research Infrastructure; Research Personnel; Research Project Grants; Review Committee; Seminal; Standardization; Strategic Planning; Talents; Therapeutic; Translating; Translational Research; Underrepresented Minority; Universities; Work; cancer health disparity; cancer risk; clinical diagnostics; ethnic difference; improved; innovation; inter-institutional; minority disparity; minority health; minority health disparity; programs; racial difference; racial population; success; translational impact

SUMMARY The University of Hawai`i Cancer Center (UHCC) is the only National Cancer Institute-designated cancer center in Hawai`i and the Pacific. The Center's mission is to reduce the burden of cancer through research, community outreach, education and patient care with an emphasis on the unique ethnic, cultural and environmental characteristics of Hawai`i and the Pacific. In alignment with this mission, the Developmental Research Program (DRP) will draw upon areas of unique opportunity at UHCC to foster minority health research that will improve our biological understanding of ethnic/racial differences in cancer risk and outcomes in our catchment area and translate our findings into therapeutic, behavioral, and diagnostic clinical trials and interventions that address these challenges. The DRP is a central element of the P50 for developing new translational research projects in minority health that will nurture new lines of investigation, research innovation, and collaboration. The funded pilot projects will provide important preliminary data for future large research project applications and support their feasibility and impact. Also, DRP studies with translational research potential may become full SPORE projects if the DRP study incorporates a human endpoint within one of the project aims. Therefore, the DRP will be an engine for innovation in translational minority health research at UHCC. As such we have integrated its activities closely with the leadership of the P50 and that of the UHCC. Here we describe the process by which pilot projects will be solicited, reviewed, awarded, and monitored. The goal of the DRP is to identify and fund 10 new research projects and collaborations over five years that address minority health issues in UHCC's catchment area. In support of this goal, the DRP coordinate pilot funding requests, reviews, and award activities and identify areas of unique opportunity and potential collaborations. UHCC is poised to make seminal contributions to understanding and alleviating the burden of cancer in our diverse catchment area through strategic minority health and disparities research. The DRP will proactively take advantage of these advantages to foster creative work that will translate into therapeutic, behavioral, and diagnostic clinical trials and interventions that directly impact minority health. These projects will form the basis for the continued success of this minority health SPORE and expand its impact by fostering the development of new research topics.

总结